Discover a new way to find and share stories you'll love… Learn about Reading Desk

Post Profile



Court Orders Johnson & Johnson To Pay $1.2 Billion In Deceptive Marketing Case

Johnson & Johnson and a subsidiary have to pay for the way it marketed antipsychotic drug Risperdal, neglecting to mention its side effects while claiming it was safer and worked better than the competition. In Arkansas, one of 11 states in which J&J has faced legal battles over the drug, a judge ordered the company to pay $1.2 billion to make up for its alleged sins. CNNMoney reports the companies' allegedly deceptive practices caused government-subsidized healthcare services to pay for the drug, which is believed to put patients at risk of diabetes and neurological problems.
read more

share

J&J Must Pay Louisiana $257.7 Million Over Risperdal Marketing Practices - Bloomberg

Medical / Pharmaceutical : PharmaGossip (4 years ago)

Johnson & Johnson must pay $257.7 million to the state of Louisiana for making misleading claims about the safety of the company’s Risperdal antipsychotic drug, a jury concluded. Jurors in state court in Opelousas, Louisiana, found ... Read Post

J&J Ordered to Pay $327 Million Over Deceptive Risperdal Marketing Claims - Bloomberg

Medical / Pharmaceutical : PharmaGossip (3 years ago)

J&J Ordered to Pay $327 Million Over Deceptive Risperdal Marketing Claims - Bloomberg: "A Johnson & Johnson (JNJ) unit was ordered by a South Carolina judge to pay more than $327 million in penalties for deceptively marketing the an... Read Post

Risperdal - ARKANSAS COURT TOSSES $1.2B JUDGMENT AGAINST J&J BY CHUCK BARTELS ASSOCIATED PRESS

Medical / Pharmaceutical : PharmaGossip (4 months ago)

LITTLE ROCK, Ark. (AP) -- The Arkansas Supreme Court on Thursday overturned a $1.2 billion judgment against Johnson & Johnson in a lawsuit challenging the drugmaker's marketing of the antipsychotic drug Risperdal.The court ruled tha... Read Post


Copyright © 2011 Regator, LLC